drugset / Trial / NCT00279617
Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks
Phase 3
Completed
15 enrolled
Lindner Center of HOPE
UCB Pharma · collabUniversity of Cincinnati · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder.
Timeline
- Start
- 2006-01
- Primary completion
- 2009-02
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Levetiracetam | Other / unclassified | 3000 mg | — |